Capstone Therapeutics Corp. (CAPS)

USD 3.0

(-11.76%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 48.35 Million 61.56 Million 66.74 Million 45.45 Million - -
Cost of Revenue 38.74 Million 45.03 Million 50.42 Million 34.51 Million 39 Thousand 157 Thousand
Gross Profit 9.61 Million 16.53 Million 16.31 Million 10.93 Million -39 Thousand -157 Thousand
Operating Expenses 10.86 Million 12.53 Million 11.68 Million 8.54 Million 723 Thousand 397 Thousand
Selling, General and Administrative Expenses 10.86 Million 12.53 Million 11.68 Million 8.54 Million 723 Thousand 397 Thousand
Research and Development Expenses - - - - - 1.37 Million
Other Expenses - - - - - 1.37 Million
Cost and Expenses 49.61 Million 57.56 Million 62.1 Million 43.05 Million 762 Thousand 554 Thousand
Operating Income -1.25 Million 3.99 Million 4.63 Million 2.39 Million -762 Thousand -554 Thousand
Interest Expense 1.52 Million 895 Thousand 1.05 Million 710 Thousand 261 Thousand -
Income Tax Expense 234 Thousand 783 Thousand 436 Thousand -8.48 Million -24 Thousand -49 Thousand
Earnings before Tax -3.58 Million 3.09 Million 4.35 Million 1.68 Million -1.02 Million -802 Thousand
Net Income -3.81 Million 2.31 Million 3.92 Million 10.45 Million -2.07 Million -380 Thousand
Earnings Per Share Basic -36.39 14.69 49.46 107.60 -38.12 -6.99
Earnings Per Share Diluted -36.39 14.69 49.46 107.60 -38.12 -6.99
Weighted Average Shares Outstanding 157.61 Thousand 157.61 Thousand 79.27 Thousand 79.27 Thousand 54.37 Thousand 54.37 Thousand
Weighted Average Shares Outstanding (Diluted) 157.61 Thousand 157.61 Thousand 79.27 Thousand 79.27 Thousand 54.37 Thousand 54.37 Thousand
Gross Margin 0.20 0.27 0.24 0.24 - -
EBIT Margin -0.04 0.07 0.08 0.06 - -
Profit Margin -0.08 0.04 0.06 0.23 - -
EBITDA -1.74 Million 4.23 Million 5.02 Million 2.64 Million -723 Thousand -397 Thousand
Earnings Before Tax Margin -0.03 0.06 0.07 0.05 - -

Income Statement Charts